Study shows Tri-Low extract of amla’s efficacy in reducing dyslipidemia
date:Mar 26, 2019
lement. Arjuna Natural, Ltd will exhibit Tri-Low and its study results at Vitafoods Europe 2019, slated to take place in Geneva between May 7 and 9.

The study, led by Haridas Upadya, et al, was published in the BMC journal of Complimentary and Alternative Medicine in January 2019.

In this double-blind, placebo-controlled, multi-centre clinical trial, 500mg amla extract or a matching placebo capsule was administered to 98 dyslipidemia patients twice daily for 12 weeks.

Following the 12-week tr
2/8 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/01 19:40